Biotech Startups
9,603 companies tagged Biotech, with their investors and founders.
Metagen Therapeutics (γ‘γΏγΈγ§γ³γ»γ©γγ₯γΌγγ£γ―γΉ) is a biotech venture developing fecal microbiota transplantation (FMT) therapies and medical services based on gut microbiome research, including an FMT drug candidate (MGT-006) for ulcerative colitis. Based in Japan, it operates across drug discovery and medical services and runs a stool donation platform to source raw material.
5 investors
Dioseve develops reproductive cell technology that uses a proprietary differentiation-induction method to generate oocytes and ovarian somatic cells from iPS cells. The company targets fertility and infertility challenges, aiming to help people who want to have children, particularly around age-related declines in egg and sperm function.
5 investors
Modalis Therapeutics develops therapeutics using CRISPR gene-editing technology and provides its platform technology for drug development. It operates in the biotechnology sector.
5 investors
Occam Razor develops drug discovery technology using digital science to target neurodegenerative diseases, focusing initially on Parkinson's disease and brain aging.
4 investors
RegImmune develops immune-modulation therapies that use regulatory T cells to induce immune tolerance or to trigger anti-tumor immune responses. Its pipeline includes treatments targeting conditions such as graft-versus-host disease (GvHD).
4 investors
1910 Genetics develops genetic engineering and biotechnology solutions, leveraging computational and biological approaches. The company serves the biotech and life sciences industry.
4 investors
1Cell.Ai develops precision oncology diagnostics using multi-omic and single-cell analysis to generate cancer insights. The company presents research studies in the oncology and cancer diagnostics field.
4 investors
52 North Health develops the patented Aster platform, a portable finger-prick blood test and companion app that measures cell-based and soluble biomarkers to identify immunosuppressed patients at risk of neutropenic sepsis. It also builds digital tools for remote triaging and management of emergency cancer care, working with patients and clinicians to make emergency care safer.
4 investors
Aadi Bioscience develops therapies targeting mTOR-driven diseases using precision medicine and albumin-bound nanoparticle technology, applying genomic profiling to identify patients most likely to benefit from mTOR inhibition. It operates in the biotechnology and pharmaceutical sector.
4 investors
Abion is a biotech company focused on precision oncology, researching and developing novel anticancer drugs. It works to identify and commercialize new drug candidates and conduct global clinical trials for rare and hard-to-treat diseases, partnering with domestic and international biopharma companies.
4 investors
AceCann cultivates, processes, and extracts medical cannabis products aimed at the European market. The company produces its products to pharmaceutical standards for use in the medical cannabis sector.
4 investors
Acesion Pharma is a biotech company developing pharmaceutical treatments. This page presents its leadership team and board of directors.
4 investors
Acodis provides document automation software for pharmaceutical and life sciences companies to extract data from batch records, stability reports, SOPs, and regulatory documents, supporting quality management, operational excellence, regulatory affairs, and compliance functions.
4 investors
Adaptive Biotechnologies applies the genetics of the adaptive immune system to diagnostics and therapeutics, translating immune-system data into clinical insights for clinicians and biopharma companies. Its Immune Medicine Platform is used to detect, monitor, and treat disease.
4 investors
Adicet Bio develops allogeneic gamma delta CAR T cell therapies for patients with autoimmune diseases and cancer. The company works on off-the-shelf immune cell therapies based on gamma delta 1 CAR T cell technology.
4 investors
4 investors
Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma. The company focuses on respiratory care for patients with these conditions.
4 investors
4 investors
Albus Health develops clinically validated monitoring technology that tracks respiratory metrics, heart rate, and cough frequency to support clinical studies. Its team includes clinicians, respiratory and sleep researchers, biomedical engineers, and computer scientists serving the clinical research and medical technology field.
4 investors
Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals. The company develops protective antibody therapeutics for hard-to-treat diseases, with an initial focus on neurodegenerative conditions and oncology.
4 investors
Alcolase is developing a liposomal enzyme supplement that delivers three enzymes to the stomach to break down alcohol and acetaldehyde before absorption into the bloodstream, aimed at people with ALDH2 deficiency and alcohol intolerance. The company targets consumers affected by alcohol intolerance, with initial markets in Singapore and South Korea.
4 investors
Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.
4 investors
Algorithmiq develops quantum algorithms that combine classical and quantum computers to solve problems in chemistry and life sciences, with a focus on drug discovery and development for rare diseases. Its products include a quantum computer interface and proprietary quantum chemistry algorithms applicable to materials, drugs, and energy.
4 investors
ALKemist Bio develops immunotherapies targeting ALK-positive cancers, using chimeric antigen receptor (CAR) T cells and T cell receptor (TCR) engineered T cells to eliminate treatment-resistant tumors. The company focuses on oncology precision therapies for aggressive cancers including neuroblastoma and non-small cell lung cancer.
4 investors